Seroprevalence and risk factors associated with HBV and HCV infection among subjects with type 2 diabetes from South India

Udyama Juttada; T P Smina; Satyavani Kumpatla; Vijay Viswanathan

doi:10.1016/j.diabres.2019.06.003

Seroprevalence and risk factors associated with HBV and HCV infection among subjects with type 2 diabetes from South India

Diabetes Res Clin Pract. 2019 Jul:153:133-137. doi: 10.1016/j.diabres.2019.06.003. Epub 2019 Jun 9.

Authors

Udyama Juttada¹, T P Smina¹, Satyavani Kumpatla¹, Vijay Viswanathan²

Affiliations

¹ M.V. Hospital for Diabetes and Prof. M. Viswanathan Diabetes Research Center [WHO Collaborating Center for Research Education and Training in Diabetes], Royapuram, Chennai, Tamil Nadu, India.
² M.V. Hospital for Diabetes and Prof. M. Viswanathan Diabetes Research Center [WHO Collaborating Center for Research Education and Training in Diabetes], Royapuram, Chennai, Tamil Nadu, India. Electronic address: drvijay@mvdiabetes.com.

PMID: 31189089
DOI: 10.1016/j.diabres.2019.06.003

Abstract

This is a brief summary of the prevalence on Hepatitis C (HCV) and Hepatitis B (HBV) viral infections and associated risk factors in Type 2 diabetes subjects. Prevalence of HBV (9%) was higher compared to HCV (2%) infection in the screened 388 subjects. Results showed that these infections are independent of the liver damage. Risk factors prominently observed among positive HCV and HBV cases were longer duration of diabetes, hospital admission, history of jaundice and history of surgeries which enlightened the importance of hepatitis vaccination once the subject is diagnosed with diabetes.

Keywords: Hepatitis B virus; Hepatitis C virus; Risk factors; Type 2 diabetes.

MeSH terms

Cross-Sectional Studies
Diabetes Mellitus, Type 2 / complications*
Diabetes Mellitus, Type 2 / pathology
Female
Hepacivirus / pathogenicity*
Hepatitis B virus / pathogenicity*
Humans
India / epidemiology
Male
Middle Aged
Risk Factors
Seroepidemiologic Studies